Evolent Health (EVH) Shares Outstanding (Diluted Average) (2013 - 2026)

Evolent Health has reported Shares Outstanding (Diluted Average) for 14 years, with the latest figure at $111.9 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Diluted Average) fell 2.96% year-over-year to $111.9 million; the trailing twelve-month figure through Mar 2026 stood at $111.9 million (down 2.96% YoY), and the FY2025 full-year result was $114.2 million, changed 0.41% from the prior year.
• Shares Outstanding (Diluted Average) for Q1 2026 stood at $111.9 million, down from $114.2 million in the prior quarter.
• The five-year high for Shares Outstanding (Diluted Average) was $115.6 million in Q2 2025, with the low at $89.5 million in Q1 2022.
• Average Shares Outstanding (Diluted Average) over 5 years is $108.5 million, with a median of $112.3 million recorded in 2023.
• Year-over-year, Shares Outstanding (Diluted Average) gained 23.93% in 2023 and declined 2.96% in 2026.
• Tracing EVH's Shares Outstanding (Diluted Average) over 5 years: stood at $93.7 million in 2022, then increased by 18.73% to $111.3 million in 2023, then climbed by 3.08% to $114.7 million in 2024, then slipped by 0.41% to $114.2 million in 2025, then slipped by 2.02% to $111.9 million in 2026.
• The last three Shares Outstanding (Diluted Average) figures came in at $111.9 million (Q1 2026), $114.2 million (Q4 2025), and $114.1 million (Q3 2025), per Business Quant data.

Peer Comparison